title: Therapeutic and symptomatic treatment of multiple sclerosis.
abstract: The treatment of multiple sclerosis (MS) is a dynamic field that is rapidly evolving. It encompasses tow main areas. The first is the direct treatment of MS itself, having evolved from using primarily steroids to the newest immunotherapies that come from the extensive research into the immune system and the role it plays in so many diseases. The second area for treatment is in the management of the effects or symptoms resulting from MS.
authors.affiliation: Spinal Cord Injury and Neuro-Orthopedic Division, Gaylord Hospital, Wallingford, Connecticut.
authors.forename: D
authors.initials: D
authors.lastname: Rosenblum
authors.forename: M
authors.initials: M
authors.lastname: Saffir
mesh_terms: D005221:Fatigue / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D007371:Interferon-gamma / Q000627:therapeutic use; D007410:Intestinal Diseases / Q000188:drug therapy / Q000503:physiopathology; D009069:Movement Disorders / Q000188:drug therapy / Q000503:physiopathology; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D009128:Muscle Spasticity / Q000188:drug therapy / Q000503:physiopathology; D010292:Paresthesia / Q000188:drug therapy / Q000503:physiopathology; D013256:Steroids / Q000627:therapeutic use; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids; D007371:Interferon-gamma